[Controlled double-blind study for the determination of the effect of Tebonin forte in patients with cerebrovascular insufficiency].
D000368:Aged; D001809:Blood Viscosity / Q000187:drug effects; D001921:Brain / Q000378:metabolism; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004734:Energy Metabolism / Q000187:drug effects; D005260:Female; D005419:Flavonoids / Q000627:therapeutic use*; D020441:Ginkgo biloba; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D000860:Hypoxia / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D010919:Placebos; D010936:Plant Extracts; D000096983:Ginkgo Extract
D005419:Flavonoids; D006490:Hemostatics; D010919:Placebos; D010936:Plant Extracts; C063170:Ginkgo biloba extract; D000096983:Ginkgo Extract
Kontrollierte Doppelblind-Studie zum Wirksamkeitsnachweis von Tebonin forte bei Patienten mit zerebrovaskulärer Insuffizienz.